Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 30.4 | 26.1 | 17.0 | 22.8 | 1.9 | 0.0 | 1.2 | 5.1 |
Revenue growth | 16.1% | 54.1% | -25.7% | 1089.1% | | -100.0% | -76.4% | |
Cost of goods sold | 7.4 | 5.2 | 3.7 | 3.3 | 0.0 | 0.0 | 0.0 | 4.5 |
Gross profit | 22.9 | 21.0 | 13.3 | 19.6 | 1.9 | 0.0 | 1.2 | 0.6 |
Gross margin | 75.5% | 80.3% | 78.4% | 85.7% | 100.0% | | 100.0% | 12.3% |
Sales and marketing | 33.7 | 35.5 | 27.9 | 16.3 | 0.9 | | | |
Research and development | 3.5 | 14.7 | 33.8 | 27.1 | 22.4 | 6.3 | 4.3 | |
General and administrative | 24.1 | 34.1 | 30.7 | 26.5 | 15.7 | 5.1 | 2.2 | 2.1 |
EBIT | -36.2 | -65.4 | -81.0 | -52.2 | -37.1 | -11.4 | -5.3 | -5.9 |
EBIT margin | -119.3% | -250.4% | -477.6% | -228.7% | -1934.2% | | -441.0% | -116.0% |
Pre-tax income | -95.5 | -69.4 | -91.7 | -58.7 | -43.2 | -20.2 | -5.4 | -6.5 |
Income taxes | 0.0 | 0.0 | -1.1 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 1.2% | 1.2% | | | 0.0% | 0.0% |
Net income | -95.5 | -69.4 | -90.6 | -57.9 | -43.2 | -20.2 | -5.4 | -6.5 |
Net margin | -314.5% | -265.4% | -534.3% | -253.8% | -2250.7% | | -449.5% | -126.8% |
|
Diluted EPS | ($1.81) | ($2.05) | ($3.70) | ($2.94) | ($2.97) | ($15.64) | ($4.18) | ($5.00) |
Shares outstanding (diluted) | 52.8 | 33.8 | 24.5 | 19.7 | 14.6 | 1.3 | 1.3 | 1.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|